Hepion Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HEPA and buy or sell other stocks, ETFs, and their options commission-free!About HEPA
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
CEORobert T. Foster
CEORobert T. Foster
Employees25
Employees25
HeadquartersEdison, New Jersey
HeadquartersEdison, New Jersey
Founded2013
Founded2013
Employees25
Employees25
HEPA Key Statistics
Market cap63.19M
Market cap63.19M
Price-Earnings ratio-0.90
Price-Earnings ratio-0.90
Dividend yield—
Dividend yield—
Average volume325.66K
Average volume325.66K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.19
52 Week high$1.19
52 Week low$0.26
52 Week low$0.26
Stock Snapshot
With a market cap of 63.19M, Hepion Pharmaceuticals(HEPA) trades at $0.83. The stock has a price-to-earnings ratio of -0.90.
On 2025-12-20, Hepion Pharmaceuticals(HEPA) stock opened at —, reached a high of —, and a low of —.
The Hepion Pharmaceuticals(HEPA)'s current trading volume is 0, compared to an average daily volume of 325.66K.
In the last year, Hepion Pharmaceuticals(HEPA) shares hit a 52-week high of $1.19 and a 52-week low of $0.26.
In the last year, Hepion Pharmaceuticals(HEPA) shares hit a 52-week high of $1.19 and a 52-week low of $0.26.
People also own
Based on the portfolios of people who own HEPA. This list is generated using Robinhood data, and it’s not a recommendation.